Nakanishi Inc.

7716.T
Medical Instruments & Supplies
2026/08/23 Updated
Market Cap: $1.6B (¥251.6B)
Stock Price: $19.06 (¥3,030)
Exchange Rate: 1 USD = ¥158.98

【Nakanishi】Q1 2026 Earnings Results|Sales of ¥2.24 billion (YoY +21.3%)

Nakanishi's consolidated earnings for the first quarter of 2026 show sales of ¥2.24 billion (YoY +21.3%) and net income of approximately ¥400 million (YoY +803.9%), achieving significant revenue and profit growth. All segments performed well.

Importance:
Page Updated: May 14, 2026
IR Disclosure Date: May 14, 2026

Key Figures

  • Sales: ¥2,248.8 million (YoY +21.3%)
  • Net income attributable to parent company shareholders: ¥3,980 million (YoY +803.9%)
  • Total assets: ¥165.775 billion

AI要約

Performance Summary

Nakanishi’s consolidated earnings for the first quarter of 2026 recorded sales of ¥2.24 billion (YoY +21.3%), representing a revenue increase. Net income was approximately ¥400 million (YoY +803.9%) with significant profit growth. Segment-wise, sales and profits increased across the Dental, DCI, Surgical, and Mechanical Engineering divisions, aided by increased production effects and improved exchange rate gains/losses. Total assets are approximately ¥165.78 billion, with an equity ratio of 70.0%.

Outlook and Impact on Shareholders

Forecasts for the full fiscal year 2026 remain unchanged, with continued steady business performance expected. Based on the earnings growth, dividend forecasts are maintained, reflecting a proactive shareholder return and capital policy. The company aims for sustained growth through expanding overseas operations and new business development.

Segment Revenue Breakdown

Profit Margin Analysis

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Nakanishi Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →